Tenax Therapeutics, Inc.TENXNASDAQ

Revenue (LTM)

Net Income (LTM)

$-53M

-198.8% YoY

Free Cash Flow

$-36M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.0B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	0	0	0	0	0
Gross Profit	0	0	0	0	0
Operating Income	-33	-11↑66.2%	-8↑25.5%	-19↓136.8%	-56↓189.2%
Net Income	-32	-11↑66.0%	-8↑30.2%	-18↓128.3%	-53↓198.8%
EBITDA	-32	-11↑66.2%	-8↑29.7%	-18↓128.9%	-56↓220.8%
EPS Diluted	-2524.80	-600.80↑76.2%	-31.04↑94.8%	-1.15↑96.3%	-1.34↓16.5%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	6	2↓62.0%	10↑361.1%	95↑868.6%	98↑2.9%
Total Current Assets	6	3↓43.6%	12↑264.1%	97↑727.5%	104↑7.8%
Total Assets	6	3↓43.2%	12↑243.2%	97↑727.5%	104↑7.8%
Total Current Liabilities	2	2↑18.1%	4↑94.1%	5↑30.9%	7↑52.5%
Total Liabilities	2	2↑9.4%	4↑87.6%	5↑30.9%	7↑52.5%
Total Equity	4	1↓64.8%	8↑442.5%	92↑1036.0%	97↑5.5%
Total Debt	0	1↑177.8%	1↓38.0%	0	0
Net Debt	-5	-1↑75.1%	-9↓606.1%	-95↓920.9%	-98↓2.9%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-11	-12↓10.7%	-6↑50.9%	-15↓150.9%	-36↓141.7%
Capital Expenditure	-0	-0↑55.7%	0	0	0
Free Cash Flow	-11	-12↓10.6%	-6↑50.9%	-15↓150.9%	-36↓141.7%
Stock-Based Comp	0	0	0	1↑489.0%	0
Net Change in Cash	-1	-3↓419.3%	8↑321.6%	85↑1009.3%	3↓96.8%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance